Langerhans cells are critical in epicutaneous sensitization with protein antigen via thymic stromal lymphopoietin receptor signaling. by Nakajima, Saeko et al.
Title
Langerhans cells are critical in epicutaneous sensitization with
protein antigen via thymic stromal lymphopoietin receptor
signaling.
Author(s)
Nakajima, Saeko; Igyártó, Botond Z; Honda, Tetsuya; Egawa,
Gyohei; Otsuka, Atsushi; Hara-Chikuma, Mariko; Watanabe,
Norihiko; Ziegler, Steven F; Tomura, Michio; Inaba, Kayo;
Miyachi, Yoshiki; Kaplan, Daniel H; Kabashima, Kenji
CitationThe Journal of allergy and clinical immunology (2012), 129(4):1048-1055.e6
Issue Date2012-04
URL http://hdl.handle.net/2433/155085




Nakajima et al                                                      1 
 
Langerhans cells are critical in epicutaneous sensitization with protein antigen via 1 




, MD, Botond Igyarto
2
, PhD, Tetsuya Honda1, MD, PhD, Gyohei 4 
Egawa
1
, MD, PhD, Atsushi Otsuka
1
, MD, PhD, Mariko Hara-Chikuma
1,3
, PhD, 5 
Norihiko Watanabe
3






, PhD, Kayo 6 
Inaba
5
, PhD, Yoshiki Miyachi
1
, MD, PhD, Daniel H Kaplan
2
, MD, PhD, and Kenji 7 
Kabashima
1
, MD, PhD 8 
 9 
1
Department of Dermatology and 
3
Center for Innovation in Immunoregulative 10 
Technology and Therapeutics, Kyoto University Graduate School of Medicine 11 
2
Department of Dermatology, Center for Immunology, University of Minnesota 12 
4
Immunology Program, Benaroya Research Institute, Seattle, Washington 98101, USA 13 
5
 Department of Animal Development and Physiology, Kyoto University Graduate 14 
School of Biostudies, Kyoto, Japan 15 
Address correspondence and reprint requests to: Dr. Kenji Kabashima 16 
Department of Dermatology, Kyoto University Graduate School of Medicine 17 
54 Shogoin Kawara, Sakyo, Kyoto 606-8507, Japan 18 
Tel: +81-75-751-3310, Fax: +81-75-761-3002 19 
Email address: kaba@kuhp.kyoto-u.ac.jp 20 
 21 
Declaration of all sources of funding 22 
This work was supported in part by Grants-in-Aid for Scientific Research from the 23 
Ministries of Education, Culture, Sports, Science and Technology (K.K.), and by a 24 
Nakajima et al                                                      2 
 
Grant-in-Aid from the Japan Society for the Promotion of Science Fellows (N.S.). The 25 
authors have no conflicting interests. 26 
 27 
 28 













Nakajima et al                                                      3 
 
Abstract  42 
Background: Clarification of cutaneous dendritic cell (DC) subset and the role of 43 
thymic stromal lymphopoietin (TSLP) signaling in epicutaneous sensitization with 44 
protein antigens, as in the development of atopic dermatitis (AD), is a crucial issue. 45 
Objectives: Since TSLP is highly expressed in the vicinity of Langerhans cells (LCs), 46 
we sought to clarify our hypothesis that LCs play an essential role in epicutaneous 47 
sensitization with protein antigens through TSLP signaling. 48 
Methods: Using Langerin-diphtheria toxin receptor knockin mice and human 49 
Langerin-diphtheria toxin A transgenic mice, we prepared mice deficient in LC. We also 50 
prepared mice deficient in TSLP receptor in LCs using TSLP receptor deficient mice 51 
with bone marrow chimeric technique. We applied these mice to an ovalbumin-induced 52 
epicutaneous sensitization model.  53 
Results: Upon the epicutaneous application of OVA, conditional LC-depletion 54 
attenuated the development of clinical manifestations as well as serum OVA-specific 55 
IgE increase, OVA-specific T cell proliferation, and IL-4 mRNA expression in the 56 
draining lymph nodes. Consistently, even in the steady state, permanent LC depletion 57 
resulted in decreased serum IgE levels, suggesting that LCs mediate Th2 local 58 
environment. In addition, mice deficient in TSLP receptor on LCs abrogated the 59 
induction of OVA-specific IgE levels upon epicutaneous OVA sensitization.  60 
Conclusion: LCs initiate epicutaneous sensitization with protein antigens and induce 61 
Th2-type immune responses via TSLP signaling. 62 
  63 
Clinical implications  64 
TSLP receptors on LCs can be a therapeutic target of skin inflammatory reactions 65 
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induced by epicutaneous sensitization with protein antigens, such as in the development 66 
of atopic dermatitis. 67 
 68 
Capsule summary 69 
LCs initiate epicutaneous sensitization with protein antigens and induce Th2-type 70 
immune responses via TSLP-TSLP receptor signaling. 71 
 72 
Key words: Langerhans cell, TSLP, TSLP receptor, epicutaneous sensitization, protein 73 
antigen 74 
 75 
Abbreviations used 76 
AD, atopic dermatitis 77 
BM, bone marrow 78 
BMC, bone marrow chimera 79 
CCR, CC chemokine receptor 80 
DCs, dendritic cells 81 
DTA, diphtheria toxin subunit A 82 
DTR, diphtheria toxin receptor 83 
EGFP, enhanced green fluorescent protein 84 
LCs, Langerhans cells 85 
LN, lymph node 86 
MDC, macrophage-derived chemokine 87 
MFI, mean fluorescence intensity 88 
OVA, ovalbumin 89 
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TARC, thymus and activation-regulated chemokine 90 
TSLP, thymic stromal lymphopoietin 91 
TSLPR, TSLP receptor 92 
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INTRODUCTION 123 
Skin plays an important immunological role by eliciting a wide variety of immune 124 
responses to foreign antigens (1). Atopic dermatitis (AD) is a pruritic chronic retractable 125 
inflammatory skin disease that is induced by the complex interaction between 126 
susceptibility genes encoding skin barrier components and stimulation by protein 127 
antigens (2, 3). Patients with AD exhibit compromised barrier function that leads to the 128 
activation of keratinocytes and immune cells, which favors a Th2 bias. A wide array of 129 
cytokines and chemokines interact to yield symptoms that are characteristic of AD. For 130 
example, thymus and activation-regulated chemokine (TARC/CCL17) and 131 
macrophage-derived chemokine (MDC/CCL22) both attract Th2 cells through CC 132 
chemokine receptor 4 (CCR4) (4), levels of which correlate well with the severity of 133 
AD (5). Elevation of serum IgE levels is also frequently found in patients with AD, 134 
sometimes concomitant with food allergy, allergic rhinitis, and asthma (3). Yet it 135 
remains unknown how elevation of serum IgE levels to protein antigens is induced in 136 
the pathogenesis of AD.         137 
  Upon protein antigen exposure, dendritic cells (DCs) acquire antigens and stimulate 138 
the proliferation of T cells to induce distinct T helper cell responses to external 139 
pathogens (6). Therefore, it has been suggested that DCs initiate AD in humans (7), 140 
however, it remains unclarified which cutaneous DC subset initiates epicutaneous 141 
sensitization to protein antigens. In the mouse skin, there are at least three subsets of 142 
DCs: LCs in the epidermis, and Langerin-positive and Langerin-negative DCs in the 143 
dermis (Langerin
+ 
dermal DCs and Langerin
- 
dermal DCs, respectively) (8-10). It has 144 
been reported that application of large molecules are localized above the size-selective 145 
barrier, tight junction (TJ), and that activated LCs extend their dendrites through the TJ 146 
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to take up antigens (11). Therefore, it can be hypothesized that not dermal DCs but 147 
rather LCs initiate epicutaneous sensitization with protein antigens, as in the 148 
development of AD.  149 
  In human, polymorphisms in the gene encoding the cytokine thymic stromal 150 
lymphopoietin (TSLP) are associated with the development of multiple allergic 151 
disorders through TSLP receptor (TSLPR), which is expressed in several cell types, 152 
such as DCs, T cells, B cells, basophils, and eosinophils (12, 13). Thus, TSLP seems to 153 
be a critical regulator of Th2 cytokine-associated inflammatory diseases. 154 
  Recently, it has been reported that basophils induce Th2 through TSLPR (13). On the 155 
other hand, it is also known that skin DCs elicit a Th2 response in the presence of 156 
mechanical injury by inducing cutaneous TSLP (14), and that LCs are critical in the 157 
development of skin lesions induced by the topical application of vitamin D3 analogues 158 
through TSLP signaling (15). However, these skin inflammation models are induced in 159 
an antigen-independent manner; therefore, it is important to address the degree to how 160 
TSLP is essential in Th2 shifting and to identify the cells that are essential for TSLP 161 
signaling transduction upon epicutaneous sensitization, which is relevant to 162 
inflammatory skin diseases, such as AD. This will lead to the understanding of the 163 
underlying mechanism and to develop new therapeutic targets for inflammatory skin 164 
diseases. 165 
  It is known that TSLP activates human epidermal LCs and DCs in vitro (16-18) and 166 
that TSLP is highly expressed in the epidermis of the lesional skin of AD patients. Since 167 
LCs are localized in the epidermis, we hypothesized that LCs initiate epicutaneous 168 
sensitization through TSLP signaling. By applying an LC ablation system, we found 169 
that LCs are crucial for Th2 induction and IgE production upon epicutaneous protein 170 
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exposure through TSLP signaling. 171 
 172 
MATERIALS AND METHODS 173 
Animals and bone marrow chimera 174 
C57BL6 (B6) and BALB/c mice were purchased from Japan SLC (Shizuoka, Japan). 175 
OT-II TCR transgenic mice were purchased from the Jackson Laboratory (Bar Harbor, 176 
ME, USA). Langerin-DTA mice were generated by Dr. Daniel Kaplan (19), and 177 
Langerin-eGFP-DTR knock-in mice were kindly provided by Dr. Bernard Mallissen 178 
(CIML, Institut National de la Santé et de la Recherche Médicale, Marseille, France).  179 
  TSLPR
-/-
 mice (BALB/c or B6 background) were generated by Dr. Steven Ziegler 180 
(20). Seven- to twelve-week-old female mice bred in specific pathogen-free facilities at 181 
Kyoto University were used for all experiments.  182 
  For LC depletion specifically, Langerin-eGFP-DTR mice were used. Intraperitoneal 183 
injection of 1 g DT (Sigma-Aldrich, St. Louis, MO, USA, in 500 l of PBS) depleted 184 
Langerin
+




dermal DCs 185 
in the dermis recover one week after DT injection, but LCs remain undetectable for four 186 
weeks after depletion (21). Since only LCs are depleted between one and three weeks 187 
after DT injection, we can evaluate the role of LCs in epicutaneous sensitization by 188 
applying OVA between one and three weeks after DT injection. Therefore, we injected 189 
DT seven days before epicutaneous sensitization. Control mice were intraperitoneally 190 
injected with 500 l of PBS on the same day. 191 
  To generate bone marrow chimeric mice, 6-week-old mice were irradiated (9 Gy) and 192 
transplanted with bone marrow cells (1 x 10
7
 cells/recipient). All experimental 193 
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procedures were approved by the institutional animal care and use committee of Kyoto 194 
University Graduate School of Medicine. 195 
 196 
Epicutaneous sensitization  197 
Mice were anesthetized with diethylethel (Nacalai Tesque, Kyoto, Japan), and then 198 
shaved with an electric razor (THRIVE Co. Ltd., Osaka, Japan). A single skin site on 199 
each mouse was tape-stripped at least five times with adhesive cellophane tape 200 
(Nichiban, Tokyo, Japan). One hundred g of OVA in 100 l of normal saline or 201 
placebo (100 l of normal saline) was placed on patch-test tape (Torii Pharmaceutical 202 
Co., Ltd., Tokyo, Japan). Each mouse had a total of three two-day exposures to the 203 
patch, separated by one-day intervals. Mice were euthanized at the end of the third cycle 204 
of sensitization (day 9). 205 
 206 
Antigen-specific T cell proliferation  207 
To assess the OVA-specific T cell priming capacity of cutaneous LCs, 100 l of normal 208 
saline with or without 100 g of OVA was placed on the shaved and tape-stripped 209 
mouse back skin. CD4 T cells were isolated from OT-II mice using magnetic bead 210 
separation (Miltenyi Biotec, Bergisch Gladbach, Germany) and labeled with 8 M 211 
CFSE. Forty-eight hours after epicutaneous sensitization, 5 x 10
6
 CFSE labeled OT-II T 212 
cells were transferred to naïve mice via the tail vein. An additional 48 hours later, skin 213 
draining brachial lymph nodes (LNs) were collected and analyzed by means of flow 214 
cytometry. 215 
 216 
Statistical analysis   217 
Nakajima et al                                                      10 
 
Unless otherwise indicated, data are presented as means ± standard deviations (SD), and 218 
each data point is representative of three independent experiments. P values were 219 
calculated according to the two-tailed Student’s t-test. 220 
 221 
A complete description of the materials and methods, and any associated references are 222 
available in the Online Repository. 223 
 224 
RESULTS  225 
LC depletion impaired the development of OVA-induced allergic skin dermatitis 226 
model 227 
To assess the role of LCs in epicutaneous sensitization with protein antigens and 228 
induction of IgE, we applied OVA to mice epicutaneously (22). In this model, we 229 
observed a rise in OVA-specific serum IgE and IgG1, both of which are induced in a 230 
Th2-dependent manner, as well as the development of dermatitis characterized by the 231 
infiltration of CD3
+
 T cells, eosinophils, and neutrophils and local expression of mRNA 232 
for the cytokines interleukin (IL)-4, IL-5, and interferon (IFN)-(22). These findings 233 
exhibited characteristics of allergic skin inflammation such as AD. To evaluate the roles 234 
of LCs, we used knock-in mice expressing enhanced green fluorescent protein (EGFP) 235 
and diphtheria toxin receptor (DTR) under the control of the Langerin gene, called 236 
Langerin-eGFP-DTR mice (23).  237 
  In the OVA-induced allergic skin dermatitis model, LC-depleted mice showed milder 238 
clinical manifestations than LC-non-depleted mice did (Fig. 1A, left panel). Histology 239 
of the patched skin area showed pronounced lymphocyte infiltration and edema in the 240 
dermis of sensitized LC-non-depleted mice, which was less apparent in sensitized 241 
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LC-depleted mice (Fig. S1A, B). The histological score of LC-depleted mice was also 242 
lower than that of LC-non-depleted mice (Fig. 1A, right panel). In addition, serum 243 
OVA-specific IgE and IgG1 levels in LC-depleted mice were significantly lower than 244 
those in wild-type (WT) mice (Fig. 1B). On the other hand, the Th1-dependent 245 
immunoglobulin IgG2a was not induced by application of OVA (Fig. 1B). These data 246 
suggest that LCs are involved in the development of OVA-induced AD-like skin 247 
inflammation and induction of IgE.  248 
 249 
Impaired T cell proliferation and Th2 induction by LC depletion 250 
Priming of antigen-specific Th2 cells and proliferation is an important step in the 251 
development of this model. To assess the T cell priming capacity of cutaneous LCs 252 
upon protein allergen exposure, LC-depleted and non-depleted mice were sensitized 253 
with OVA percutaneously on the back and transferred with carboxyfluorescein 254 
succinimidyl ester (CFSE)-labeled OT-II T cells which express an OVA-specific T cell 255 
antigen receptor. Next, single-cell suspensions prepared from the skin-draining brachial 256 
lymph nodes (LNs) were analyzed by means of flow cytometry to evaluate T cell 257 
division by LCs in the draining LNs. LC-depleted mice showed impaired T cell division 258 
after OVA sensitization compared with LC non-depleted mice, suggesting that LCs 259 
stimulate T cell proliferation, at least to some degree, in this model (Fig. 2A and B).  260 
  To evaluate the role of LCs in T cell priming, we examined the mRNA expression of 261 
Th2 cytokine IL-4 and Th1 cytokine IFN- in draining LNs after OVA sensitization. 262 
The IL-4 mRNA expression level of draining LNs was significantly decreased in 263 
LC-depleted mice, while the IFN- mRNA expression level was significantly higher in 264 
LC-depleted mice than in LC-non-depleted mice (Fig. 2C). These results suggest that 265 
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LCs are crucial for stimulating T cell proliferation to a certain extent and Th2 induction 266 
pronouncedly in skin-draining LNs in this model.  267 
 268 
LCs are responsible for initiating epicutaneous sensitization to protein antigens  269 
It has been reported that LCs are dispensable for initiating contact hypersensitivity to 270 
haptens, which may cast a discrepancy to our findings on the necessity of LCs to protein 271 
antigen sensitization (21, 24). To evaluate the extent of skin penetration by protein 272 
antigens and haptens, we patched fluorescein isothiocyanate (FITC)-conjugated OVA or 273 
painted FITC on the back skin of B6 mice, and performed immunohistochemical 274 
analysis. FITC-conjugated OVA retained above the TJ was indicated by staining with 275 
anti-claudin-1 antibody (Fig. S2, left panel). On the other hand, when we painted FITC 276 
on the skin of the mouse back skin, it readily penetrated into the dermis where dermal 277 
DCs locate (Fig. S2, right panel).  278 
   279 
LCs are critical for IgE production 280 
To further assess the role of LCs in IgE production, we used gene-targeted 281 
Langerin-diphtheria toxin subunit A (DTA) mice (named Langerin-DTA mice), which 282 
constitutively lack LCs throughout life (19). WT and Langerin-DTA mice were bred 283 
under SPF conditions for six to ten weeks, and serum IgE levels were measured by 284 
means of ELISA. On the FVB background, the serum IgE level was lower in 285 
Langerin-DTA mice than in WT controls (Fig. 3A, left panel), while no significant 286 
difference was seen on the C57BL/6 (B6) background (Fig. 3A, right panel). We also 287 
found that the expression level of IgE on peritoneal mast cells was decreased in 288 
LC-deficient mice in both the FVB and B6 backgrounds (Fig. 3B). Pre-incubation of 289 
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mast cells with IgE in vitro did not change the data arguing that surface expression of 290 
FcRI on mast cells was decreased in LC deficient mice, which is an indicator of lower 291 
serum IgE. Therefore, the above data strongly suggest that LCs are crucial for IgE 292 
production, which is consistent with the findings in the OVA-induced skin 293 
inflammation model (Fig. 1, Fig. 2). 294 
 295 
TSLP receptor on LCs is upregulated by protein antigen exposure 296 
It has been reported that TSLP is involved in exacerbation of mouse Th2-mediated 297 
allergic inflammation through direct stimulation of Th2 effector cells (25). However, it 298 
remains unknown which cells initiate Th2 induction via TSLP signaling under 299 
epicutaneous sensitization of protein antigens. TSLP is highly expressed in the skin 300 
lesions of human AD (17, 18, 26, 27), and the major cells in proximity to keratinocytes 301 
are LCs; therefore, we evaluated the effect of TSLPR expression on LCs. We found that 302 
LCs expressed TSLPR, but the expression level was low under the steady state. On the 303 
other hand, the expression level of TSLPR on LCs was pronouncedly enhanced by 304 
topical application of OVA (Fig. 4). 305 
 306 
Establishment of BMC mice deficient in TSLPR on LC 307 
Next we sought to clarify the significance of TSLP in epicutaneous sensitization with 308 
protein antigens and to identify responsible cells mediating TSLP signaling. Since cells 309 
ensuring epidermal LC renewal are radioresistant, LCs and their derivatives found in 310 
skin-draining LNs are of host origin (28). We irradiated B6 mice and B6 background 311 
TSLPR-deficient (TSLPR
-/-
) mice, and then transferred bone marrow cells from B6 312 
mice into the irradiated mice. TSLPR is expressed on not only LCs, but also T cells, B 313 
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cells, basophils, eosinophils, and dermal DCs. Of note LCs are radioresistant while T 314 
cells, B cells, basophils, eosinophils, and dermal DCs are radiosensitive. When mice 315 
were irradiated and transplanted with bone marrow cells, more than 95% of the blood 316 
cells in the recipient mice had been replaced with donor-derived cells within two 317 
months after the transfer, whereas almost 100% of LCs were derived from the host, 318 
unlike the vast majority of dermal DCs that were donor-derived at this point (Fig. 5A). 319 
Therefore, given that TSLPR
-/-
 mice were reconstituted with bone marrow cells from B6 320 
mice, these mice were deficient in TSLPR on LCs, but other bone marrow-derived cells 321 
expressing TSLPR were present. Accordingly, using a hematopoietic bone marrow 322 
chimeric (BMC) system, we generated mice in which TSLPRs were lacking in LCs 323 
(LC-TSLPR
-/-
 BMC mice) (Fig. S3). 324 
 325 
Essential target of TSLP is TSLPR on LCs in OVA-induced allergic skin 326 
dermatitis model 327 
In the context of OVA-induced AD-like skin inflammation, LC-TSLPR
-/-
 BMC mice 328 
showed milder clinical and histological findings than TSLPR
+/+
 BMC mice did, but 329 
these findings were nearly comparable with those of TSLPR
-/-
 BMC mice (Fig. 5B, Fig. 330 
S4). Consistently, OVA-specific IgE levels in the serum after OVA challenge were 331 
significantly lower in LC-TSLPR
-/-
 BMC mice than in TSLPR
+/+
 BMC mice (Fig. 5C). 332 
These data indicate LCs play an important role in epicutaneous sensitization upon 333 
protein antigens in accord with IgE induction through TSLP-TSLPR signaling. 334 
 335 
TSLPR on LCs are dispensable for antigen-specific T cell proliferation, but vital 336 
for Th2 induction 337 
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The above results suggest that LCs stimulate T cells to differentiate into Th2, resulting 338 
in IgE induction. To clarify this issue, we assessed the T cell proliferation and 339 
differentiation capacity of LCs in the presence or absence of TSLPR. We transferred 340 
CFSE-labeled OT-II T cells into mice topically treated with OVA, and dividing cells in 341 
the draining LNs were measured by means of flow cytometry (Fig. 6A). The ratio of 342 
dividing OT-II CD4
+
 T cells to undivided OT-II CD4
+







 BMC mice (Fig. 6B). In addition, 344 
IFN- mRNA level in the draining LNs 96 hours after OVA application was similar 345 
among these three groups (Fig. 6C). On the other hand, the IL-4 mRNA expression 346 
level in skin-draining LNs was significantly lower in LC-TSLPR
-/-
 BMC mice than in 347 
the other two groups (Fig. 6C). These results indicate that TSLPR on LCs are 348 
dispensable for antigen-specific T cell proliferation but vital for inducing Th2 349 
differentiation. 350 
 351 
TSLP promotes expression of OX40L and production of Th2 chemokines by DCs 352 
We next sought to elucidate the mechanism underlying Th2 induction of LCs via 353 
TSLP-TSLPR signaling. Modulation of costimulatory molecule expression was among 354 
the candidates, as it has been demonstrated that the interaction between membrane 355 
OX40L on DCs and OX40 on naive T cells results in the induction of IL-4 production 356 
by T cells in humans (26), and that treating mice with OX40L-blocking antibodies 357 
substantially inhibited Th2 immune responses induced by TSLP in the lung and skin 358 
(29).  359 
  Therefore, it is important to evaluate the expression levels of costimulatory molecules 360 
on LCs in OVA-sensitized skin by means of flow cytometry. TSLPR
-/-
 (BALB/c 361 
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background) and WT control BALB/c mice were sensitized with OVA percutaneously. 362 
Seventy-two hours later, epidermal cell suspensions were prepared and stained with 363 
anti-OX40L, CD80, and CD40 antibodies. The MFI of OX40L expressed by LCs from 364 
OVA-sensitized TSLPR
-/-
 mice was significantly lower than that in WT control mice. 365 
On the other hand, expression levels of CD40 and CD80 on LCs were comparable 366 
between WT control and TSLPR
-/- 
mice (Fig. S5A).  367 
  It is known that serum levels of CCL17 and CCL22 correlate with the severity of AD 368 
(5). We incubated bone marrow-derived DCs (BMDCs) from BALB/c mice with 369 
recombinant mouse TSLP, and found that TSLP induced DCs to express CCL17 and 370 
CCL22 mRNA (Fig. S5B), while the expression level of the Th1 chemokine CXCL10 371 
was suppressed by TSLP (Fig. S5C). These results suggest that TSLP instructs 372 
cutaneous DCs to create a Th2-permissive microenvironment by modulating the 373 
expression levels of chemokines.   374 
 375 
DISCUSSION 376 
In this study, we have demonstrated that LCs are the essential cutaneous DC subset in 377 
the induction of IgE upon epicutaneous sensitization with protein antigens. We also 378 
found that TSLPR expression on LCs is enhanced upon protein antigen exposure to the 379 
skin and that LCs plays an important role in this process through TSLP-TSLPR 380 
signaling. In addition, we have demonstrated that TSLP stimulation causes LCs to 381 
express OX40L as shown previously in human studies, and that BMDCs induce Th2 382 
chemokines while suppressing Th1 chemokines, which may shift the immune 383 
environment to a Th2 milieu.  384 
  While a previous report suggests the significance of LCs in the induction of Th2 385 
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immune responses in humans (30), other studies have reported that dermal DCs, but not 386 
LCs, are essential for murine epicutaneous sensitization with hapten, as in contact 387 
hypersensitivity that is mediated by Th1 (19, 21, 31, 32). In our study, we have 388 
demonstrated that LCs seem to be indispensable for Th2 induction upon protein antigen 389 
sensitization. Therefore, dermal DCs and LCs may play an important role for Th1 and 390 
Th2 type immune reactions, respectively.  391 
  While protein antigens remain above the TJ, haptens can readily penetrate into the 392 
dermis as shown in Fig. S2; therefore, LCs may not be essential for sensitization to 393 
hapten as reported previously (21, 24). Upon protein antigen exposure to the skin, on 394 
the other hand, LCs are vital in the induction of antigen-specific IgE. It is still an 395 
intriguing issue how clinical and histological scores, T cell proliferation, and IL-4 396 
production were only partially suppressed by deficiency of LCs. These results suggest 397 
that other antigen presenting cells, such as dermal DCs, might be able to induce 398 
antigen-specific T cell proliferation in the draining LNs and that other Th2 inducing 399 
cells, such as basophils and mast cells, may contribute to produce IL-4 in the draining 400 
LNs. These issues need to be answered in the future. 401 
  It has been reported that basophils induce Th2 through TSLPR and that LCs are 402 
essential in the vitamin D3 induced-skin lesions through TSLP signaling (13, 15). In this 403 
study, we have demonstrated the significance of TSLP-TSLPR signaling on LCs under 404 
epicutaneous sensitization with protein antigens, which is clinically relevant to AD. Our 405 
findings will lead to the understanding of underlying mechanism and developing new 406 
therapeutic targets for inflammatory skin diseases.  407 
 408 
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FIGURE LEGENDS 505 
FIG 1. LCs are crucial for epicutaneous sensitization with OVA.  506 
(A) Total clinical severity scores (left panel) and total histology scores (right panel) of 507 
LC-non-depleted (LC+) and LC-depleted (LC-) mice (n = 5 mice per group). (B) Serum 508 
OVA-specific antibodies as determined by ELISA. Optical density value for IgE, IgG1, 509 
and IgG2a levels were measured at a wavelength of 450 nm. *, P< 0.05 510 
 511 
FIG 2. LCs are critical for antigen-specific T cell proliferation. 512 
Mice in the presence or absence of LCs (LC+ and LC-, respectively) were treated with 513 
OVA and transplanted with CFSE-labeled OT-II T cells (n = 5 mice per group). 514 
Skin-draining LNs were analyzed for OVA-specific T cell proliferation (A and B) and 515 
mRNA expression levels for IFN- and IL-4 (C). Boxes in (A) demarcate divided cells 516 
(left) and undivided cells (right) *, P< 0.05. N.D., not detected.  517 
 518 
FIG 3. LCs are essential for IgE production.  519 
(A) The serum IgE levels and (B) IgE expression levels on peritoneal mast cells 520 
(indicated by MFI) of WT and Langerin-DTA mice on FVB (left panel) and B6 (right 521 
panel) backgrounds. Mast cells were also pre-incubated with IgE (labeled with pre IgE) 522 
in vitro before measurement of IgE expression (B). Each symbol represents an 523 
individual animal. *, P < 0.05. 524 
 525 
FIG 4. TSLPR on LCs is a responsible target of TSLP upon epicutaneous OVA 526 
sensitization.  527 
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Epidermal cell suspensions from B6 (WT) mice with (sensitized) or without 528 
(non-sensitized) epidermal application of OVA were stained with TSLPR antibody. 529 




 LCs was analyzed by flow cytometry 530 
(left, histogram; right, average + SD of MFI). n = 3 per group. *, P < 0.05.  531 
 532 
FIG 5. An essential target of TSLP for IgE induction is TSLPR on LCs. 533 
(A) B6 (Ly45.2) mice were irradiated and transplanted with BM cells from B6 (Ly45.1) 534 
mice. The epidermis and dermis of BMC mice separated, and single-cell suspensions 535 
were stained and analyzed by flow cytometry. 536 




-/- BMC, and TSLPR
-/-
 BMC mice (n=5 mice per group). 538 
(C) Serum OVA-specific antibodies as determined by ELISA. Optical density value for 539 
IgE, IgG1, and IgG2a levels were measured at a wavelength of 450 nm. *, P< 0.05.  540 
 541 




-/- BMC, and TSLPR
-/-
 BMC mice were treated with OVA 543 
or saline and transplanted with CFSE-labeled OT-II T cells. Skin-draining LNs were 544 
analyzed for OVA-specific T cell proliferation (A and B) and cytokine mRNA 545 
expression levels for IFN- and IL-4 (C). Boxes in (A) demarcate divided cells (left) 546 
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 11 
SUPPLEMANTAL MATERIALS AND METHODS 12 
Cell culture, reagents, antibodies, and flow cytometry 13 
The complete RPMI (cRPMI) culture medium consisting of RPMI 1640 (Invitrogen, 14 
Carlsbad, CA, USA) containing 10% heat-inactivated fetal calf serum, 5 x 10
-5
 M 15 
2-mercaptoethanol, 2 mM L-glutamine, 25 mM 16 
N-2-hydroxyethylpiperazine-N’-2-ethanesulfonic acid, 1 mM nonessential amino acids, 17 
1 mM sodium pyruvate, 100 units/mL penicillin, and 100 g/mL streptomycin, was 18 
used, unless otherwise indicated. 19 
  For bone marrow-derived DC (BMDC) culture, 5 x 10
6
 BM cells generated from WT 20 
and TSLPR
-/-
 mice were cultured in 10 mL of cRPMI supplemented with 3 ng/mL 21 
recombinant murine granulocyte-macrophage colony-stimulating factor (PeproTech, 22 
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 2 
Rocky Hill, NJ, USA) for 5 to 7 days. Then, 5 x 10
5
 cells were seeded in a 24-well 23 
culture dish (Nunc, Rochester, NY, USA) in 500 l cRPMI and stimulated with 100 24 
ng/ml recombinant mouse TSLP (R&D Systems, Minneapolis, MN, USA) for six hours. 25 
  For epidermal cell suspensions, dorsal skin sheets were floated on dispase II (GODO 26 
SHUSEI CO., LTD, Aomori, Japan) diluted to 5 mg/ml in cRPMI for one hour at 37°C 27 
and 5% CO2. The epidermis was separated from the dermis with forceps in RPMI 28 
medium supplemented with 2% fetal calf serum. The isolated epidermis was cut finely 29 
with scissors and floated in 0.25% trypsin-EDTA for 10 min at 37°C and 5% CO2, and 30 
filtered through a 40-m cell strainer (BD Bioscience, San Diego, CA, USA).  31 
  We purchased OVA from Sigma-Aldrich, and carboxyfluorescein succinimidyl ester 32 
(CFSE) was acquired from Invitrogen. Fluorochrome-conjugated antibodies to CD4, 33 
CD11c, CD90.1, MHC class II, OX40L, CD40, and CD80 were purchased from 34 
eBioscience Inc. (San Diego, CA, USA). Anti-mouse TSLPR and isotype control were 35 
purchased from R&D systems. Cells were analyzed using the FACS LSR Fortessa flow 36 
cytometric system (BD Bioscience) and FlowJo software (Tree Star, Ashland, OR, 37 
USA). 38 
 39 
Histology, and allergen penetration in the skin  40 
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 3 
The clinical severity of skin lesions was scored according to the macroscopic diagnostic 41 
criteria that were used for the NC/Nga mouse (4). In brief, the total clinical score for 42 
skin lesions was designated as the sum of individual scores, graded as 0 (none), 1 (mild), 43 
2 (moderate), and 3 (severe), for the symptoms of pruritus, erythema, edema, erosion, 44 
and scaling. Pruritus was observed clinically for more than two minutes. 45 
   For histological examination, tissues were fixed with 10% formalin in phosphate 46 
buffer saline, and then embedded in paraffin. Sections with a thickness of 5 m were 47 
prepared and subjected to staining with hematoxylin and eosin. The histological 48 
findings were evaluated as reported previously (5).  49 
  For immunohistochemical analysis, OVA-sensitized skin samples were directly 50 
frozen at -80
o
C in Tissue-Tek O.C.T. (Sakura Finetek, Tokyo, Japan). Skin cryosections 51 
were fixed with 4% paraformaldehyde (Nacalai Tesque) and permeabilized with 0.1% 52 
Triton-X (Sigma-Aldrich) in PBS for 10 minutes at room temperature. Next, slides were 53 
incubated with anti-claudin-1 polyclonal antibody (Abcam, Cambridge, UK). 54 
Immunodetection was performed using Alexa Fluor 594-coupled secondary antibody 55 
(Invitrogen). The slides were mounted in ProLong Gold Antifade reagent (Invitrogen), 56 
and fluorescence images were obtained using a BIOREVO BZ-9000 system (Keyence, 57 
Osaka, Japan). 58 
  For assessing penetration of allergen, mice were percutaneously sensitized with 100 59 
g of fluorescein isothiocyanat (FITC)-conjugated OVA (Molecular Probes, Inc., 60 
Eugene, OR, USA) diluted in 100 l normal saline onto the shaved and tape-stripped 61 
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back skin. Seventy-two hours later, immunohistochemical analysis of the skin to assess 62 
allergen penetration was performed. Similarly, 100 l of 1% FITC (Sigma-Aldrich) in 63 
acetone/dibutyl phthalate (1/1) was applied to shaved dorsal skin of B6 mice; 72 hours 64 
later, immunohistochemical analysis was performed to assess hapten penetration into 65 
the skin. 66 
 67 
ELISA for OVA-specific serum IgE 68 
Total serum IgE levels were measured using a Bio-Rad (Hercules, CA, USA) Luminex 69 
kit according to the manufacturer’s instructions. To measure OVA-specific 70 
IgE/IgG1/IgG2a levels, the appropriate mouse IgE/IgG1/IgG2a ELISA kit (Bethyl 71 
Laboratories, Montgomery, TX, USA) was used with slight modifications. Specifically, 72 
plates were coated and incubated with 10 g/ml OVA diluted with coating buffer for 2 73 
hours. After a blocking period of 30 minutes, 100 l of 5 x diluted serum was added 74 
into each well and incubated for 2 hours. Anti-mouse IgE/IgG1/IgG2a-horseradish 75 
peroxidase conjugate (1:15,000; 100 L) was used to conjugate the antigen-antibody 76 
complex for 60 minutes at room temperature; from this point on the ELISA kit was used 77 
according to the manufacturer’s instructions. Absorbance was measured at 450 nm. The 78 
difference between the sample absorbance and the mean of negative control absorbance 79 
was taken as the result. 80 
  To measure IgE levels on peritoneal mast cells, the peritoneal cavity was rinsed with 81 
10 ml of ice-cold, sterile PBS. The collected cell suspension was incubated with 82 
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 5 
Fc-block antibody (BD Biosciences; 2-4G2), washed and split in half. Half of the cells 83 
were kept untreated while the other half were incubated with 10 g/ml of anti-DNP-IgE 84 
(mouse monoclonal IgE, Sigma-Aldrich) for 40 minutes on ice. After being washed 85 
with staining media, the cells were further incubated with an anti-c-kit and anti-mouse 86 
IgE and analyzed using a flow cytometer.  87 
 88 
Quantitative reverse-transcribed PCR analysis   89 
Total RNAs were isolated with RNeasy kits and digested with DNase I (Qiagen, Hilden, 90 
Germany). cDNA was reverse transcribed from total RNA samples using the Prime 91 
Script RT reagent kit (Takara Bio, Otsu, Japan). Quantitative RT-PCR was performed by 92 
monitoring the synthesis of double-stranded DNA during the various PCR cycles, using 93 
SYBR Green I (Roche, Basel, Switzerland) and the Light Cycler real time PCR 94 
apparatus (Roche) according to the manufacturer’s instructions. All primers were 95 
obtained from Greiner Japan (Tokyo, Japan). The primer sequences were IFN-, 5’- 96 
GAA CTG GCA AAA GGA TGG TGA -3’ (forward), 5’- TGT GGG TTG TTG ACC 97 
TCA AAC -3’ (reverse); IL-4, 5’- GGT CTC AAC CCC CAG CTA GT -3’ (forward), 98 
5’- GCC GAT GAT CTC TCT CAA GTG AT -3’ (reverse); CCL17, 5’- CAG GGA 99 
TGC CAT CGT GTT TCT -3’ (forward), 5’- GGT CAC AGG CCG TTT TAT GTT -3’ 100 
(reverse); CCL22, 5’- TCT TGC TGT GGC AAT TCA GA -3’ (forward), 5’- GAG GGT 101 
GAC GGA TGT AGT CC -3’ (reverse); CXCL10, 5’- CCA AGT GCT GCC GTC ATT 102 
TTC-3’ (forward), 5’- GGC TCG CAG GGA TGA TTT CAA-3’ (reverse). The cycling 103 
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 6 
conditions were as follows: initial enzyme activation at 95°C for 10 min, followed by 104 
40 cycles at 95°C for 10 seconds, and 60°C for 20 seconds. All cycling reactions were 105 
performed in the presence of 3.5 mM MgCl2. Gene-specific fluorescence was measured 106 
at 60°C. For each sample, triplicate test reactions and a control reaction lacking reverse 107 
transcriptase were analyzed for expression of the genes, and results were normalized to 108 
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 130 
SUPPLEMENTAL FIGURE LEGENDS 131 
Figure S1. (A) H&E staining of the back skin of LC-non-depleted or LC depleted mice 132 
after OVA application for three times (H&E, original magnification x400). Scale bar, 133 
100 m. (B) The histological findings were scored by infammation, neutrophil 134 
infiltration, mononuclear cell infiltration, edema and epithelial hyperplasia. Data are 135 
presented as means ±SD (n = 5). 136 
Figure S2. Impaired penetration of protein antigen into the dermis. B6 mice were 137 
patched with FITC-conjugated OVA on the back skin; 72 hours later, patched skin area 138 
was analyzed by immunohistochemistry. FITC-conjugated OVA (green) retained above 139 
the TJ was indicated by staining with anti-claudin-1 antibody (red) (left panel). FITC 140 
(green) readily penetrated into the dermis (right panel). Blue staining (DAPI) indicates 141 
nuclei. Dashed white lines represent the border between dermis and epidermis. Scale 142 
bars, 100 m. 143 
Figure S3. Establishment of bone marrow chimeric mice deficient in TSLPR on 144 
LC (LC-TSLPR
-/-
 BMC). B6 mice and B6-background TSLPR
-/-
 mice were irradiated 145 
(IR) and transplanted with BM cells (BMT) from B6 mice or TSLPR
-/-
 mice. Since LCs 146 
were radioresistant, when TSLPR
-/-
 mice were reconstituted with BM cells from B6 147 
mice, they were deficient in TSLPR on LCs (LC-TSLPR
-/-
 BMC mice). 148 







mice after OVA application for three times (H&E, original magnication x400).Scale bar, 150 
100 m. (B)The histological findings were scored by infammation, neutrophil 151 
infiltration, mononuclear cell infiltration, edema and epithelial hyperplasia.  Data are 152 
presented as means ±SD (n = 5). 153 
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Figure S5. TSLP promotes expression of OX40L and production of Th2 154 
chemokines by DCs. (A) The expression levels of OX40L, CD80 and CD40 of LCs 155 




 mice (n = 5 156 




LC cells. (B, C) 157 
BMDCs were incubated with or without recombinant TSLP (rTSLP), and mRNA levels 158 
of chemokines, CCL17, CCL22, and CXCL10, were measured by real-time qPCR. *P 159 
<0 .05. 160 
Figure S1. (A) H&E staining of the back skin of LC-non-depleted or LC depleted mice
after OVA application for three times (H&E, original magnication x400). Scale bar, 100 µm.
(B)The histological findings were scored by infammation, neutrophil infiltration,
mononuclear cell infiltration, edema and epithelial hyperplasia. Data are pre-








































Figure S2. Impaired penetration of protein antigen into the dermis.
B6 mice were patched with FITC-conjugated OVA on the back skin; 72 hours later,
patched skin area was analyzed by immunohistochemistry.
FITC-conjugated OVA (green) retained above the TJ was indicated by staining with
anti-claudin-1 antibody (red) (left panel). FITC (green) readily penetrated into the dermis
(right panel). Blue staining (DAPI) indicates nuclei. Dashed white lines represent the border















Figure S3. Establishment of bone marrow chimeric mice deficient in TSLPR
on LC (LC-TSLPR-/- BMC).
B6 mice and B6-background TSLPR-/- mice were irradiated (IR) and transplanted
with BM cells (BMT) from B6 mice or TSLPR-/- mice. Since LCs were radioresistant,
when TSLPR-/- mice were reconstituted with BM cells from B6 mice, they were















Figure S4. (A) H&E staining of the back skin of TSLPR+/+, LC-TSLPR-/-, and
TSLPR-/- mice after OVA application for three times (H&E, original magnication x400).
Scale bar, 100 µm.
(B)The histological findings were scored by infammation, neutrophil infiltration,
mononuclear cell infiltration, edema and epithelial hyperplasia. Data are pre-
sented as means + SD (n = 5)







































Figure S5. TSLP promotes expression of OX40L and production of Th2
chemokines by DCs.
(A) The expression levels of OX40L, CD80 and CD40 of LCs with (sen+)
or without (sen-) OVA sensitization in TSLPR+/+ and TSLPR-/- mice
(n = 5 mice per group). Cells were pregated on MHC class II+ CD11c+ LC cells.
(B, C) BMDCs were incubated with or without recombinant TSLP (rTSLP),
and mRNA levels of chemokines, CCL17, CCL22, and CXCL10, were measured
by real-time qPCR. *P <0 .05.
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